A Simple, Versatile and Sensitive Cell-Based Assay for Prions from Various Species by Arellano-Anaya, Zaira E. et al.
A Simple, Versatile and Sensitive Cell-Based Assay for
Prions from Various Species
Zaira E. Arellano-Anaya, Jimmy Savistchenko, Jacinthe Mathey, Alvina Huor, Caroline Lacroux, Olivier
Andre ´oletti, Didier Vilette*
UMR INRA (Institut National de la Recherche Agronomique) ENVT (Ecole Nationale Ve ´te ´rinaire de Toulouse) 1225, Interactions Ho ˆte Agent Pathoge `ne, Toulouse, France
Abstract
Detection and quantification of prion infectivity is a crucial step for various fundamental and applied aspects of prion
research. Identification of cell lines highly sensitive to prion infection led to the development of cell-based titration
procedures aiming at replacing animal bioassays, usually performed in mice or hamsters. However, most of these cell lines
are only permissive to mouse-adapted prions strains and do not allow titration of prions from other species. In this study,
we show that epithelial RK13, a cell line permissive to mouse and bank vole prion strains and to natural prion agents from
sheep and cervids, enables a robust and sensitive detection of mouse and ovine-derived prions. Importantly, the cell culture
work is strongly reduced as the RK13 cell assay procedure designed here does not require subcultivation of the inoculated
cultures. We also show that prions effectively bind to culture plastic vessel and are quantitatively detected by the cell assay.
The possibility to easily quantify a wider range of prions, including rodent experimental strains but also natural agents from
sheep and cervids, should prompt the spread of cell assays for routine prion titration and lead to valuable information in
fundamental and applied studies.
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Introduction
Transmissible spongiform encephalopathies, or prion diseases,
are fatal degenerative disorders of the central nervous system
affecting both humans and animals. They are characterized by
deposits of abnormal conformers of the PrP protein and the most
widely accepted model of prion multiplication is that abnormally-
folded PrP recruits and converts the host PrP into new abnormal
forms [1,2,3]. Abnormal PrP is usually isolated from infected cells
and tissues as a detergent-insoluble, protease-resistant, infectious
form, named PrP
res [4,5]. However, accumulating evidence has
recently highlighted the presence of other abnormal PrP forms
beside large PrP
res aggregates [6,7,8,9,10,11,12,13,14], some of
which may also be infectious.
The gold standard for detection and quantification of prion
infectivity relies on inoculation of appropriate animals and
determination of the time to terminal disease (incubation period
method) or the dilution at which a given sample transmits disease
to 50% of the inoculated animals (endpoint titration method).
Over more than 3 decades, a huge number of titrations have been
carried out and provided invaluable information in many aspects
of prion research [15], e.g., tissue distribution of prions. Yet
bioassays are slow, rather imprecise, costly and require dedicated
facilities and large numbers of animals. A major breakthrough was
introduced by Weissmann and collaborators showing that some
murine prion strains could be titrated in a cell-based assay named
Standard Scrapie Cell Assay (SSCA) [16]. The SSCA uses neu-
roblastoma N2a subclones highly sensitive to 22L and RML
strains of mouse prions. In this paradigm, samples to be titrated
are incubated with N2a cells grown in microtiter plates. To allow
prions to multiply to a biochemically detectable level, all individual
inoculated cultures are subpassaged at least 3 times. At the end of
the assay, individual PrP
res-containing cells are immunodetected
and automatically enumerated. The SSCA is at least as sensitive as
bioassay, cheap, rapid and robust. Since then, cell-based titrations
have been instrumental in various aspects of prion research,
including the study and the evolution of prion strains [17,18], their
kinetics of multiplication [19], their persistence in the environment
[20], the effectiveness of prion decontamination/removal proce-
dures [21,22], the spontaneous generation of prions [23] and
infectivity fractionation [10,24,25]. However, applicability is re-
stricted by the limited number of prion strains that can be
successfully assayed in N2a cells and by the time-consuming cell
culture work, even if SSCA may be suitable to automation.
In strong contrast to N2a cells that are only susceptible to mouse
prion strains, RK13 cells expressing the appropriate PrP protein
can propagate prions strains from different species [26]. Genet-
ically engineered RK13 cells are permissive to several murine
strains (22L, Chandler, Fukuoka-1, RML, MU-02) [27,28,29], to a
bank vole strain [27] and to natural prion agents from sheep
scrapie [30,31] and Chronic Wasting Disease [32]. Using sheep
and mouse prions, we investigated whether RK13 cells are
sensitive enough for cell-based detection assays of prion infectivity.
We report on an experimental procedure that allows a simple,
versatile, robust and sensitive detection of prions. More specifi-
cally, the cell culture work is strongly reduced compared with all
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passaged after challenge. Interestingly, we also show that infec-
tivity is efficiently bound by cell culture plastic and quantitatively
detected by our cell assay.
Results
Previous studies demonstrated that expression of ovine, elk,
mouse or bank vole PrP in the RK13 cell line renders the resulting
ovRK13, elRK13, moRK13 or voRK13 cells permissive to prions
of the corresponding species, as assessed by accumulation of PrP
res
and infectivity in the infected cultures [26]. By using doxycycline
(dox)-regulatable PrP constructs, no detectable PrP
res accumulates
when the cells do not express the transfected PrP, i.e.,when the
experiments are performed in the absence of dox [27,30,31].
OvRK13 cell assay of sheep prions
To determine the sensitivity of the RK13 cell assay to sheep prion
infection, we used PG127, a natural sheep scrapie isolate [33]
propagated in tg338 transgenic mice expressing the ovine PrP [34].
Infectivity of PG127 10% brain homogenate was assessed by
intracerebral inoculation of 10-fold dilutions into tg338 mice. The
last dilution inducing clinical disease in 100% of the inoculated
animals (n=6) was 10
25(the incubation period was 106 days 66d a y s ,
mean 6 SD and the calculated infectious titer was 10
7.7 LD50/ml).
This PG127 10% brain homogenate was serially diluted in cell
culture medium and 10-fold dilutions (from 10
24 to 10
26) were
applied to confluent ovRK13 cells in 6-well plates (one well per
dilution). One week later, the infected media were removed and
replaced by fresh medium. RK13 cells, like many other epithelial
cell lines [35] can be kept for weeks as viable, confluent mono-
layers of polarized cells ([36–37] and Fig. 1A). The inoculated
ovRK13 cultures were kept for 3 more weeks in the same wells (the
medium being changed once a week) and detergent-solubilized,
digested with proteinase K (PK) and assayed for PrP
res by immu-
noblotting. Transmission was scored positive when a typical PrP
res
signal (Fig. 1B, left) was observed. Data from 16 independent
transmissions carried out by 4 different operators over a 6 month-
period demonstrated positive transmission for all cultures inoc-
ulated with PG127 dilutions down to 10
25. No detectable PrP
res
was observed in cultures inoculated with 10
26 dilutions. A
representative immunoblot is shown in Fig. 1B, right. When the
experiments were performed in the absence of dox, the inoculated
cultures were PrP
res negative. This important control demonstrates
that the detected PrP
res indeed results from de novo infection of the
cells and not from residual PrP
res from the diluted inocula. In
addition, immunoblotting was not sensitive enough to detect the
very low amounts of PrP
res in the 10
25 dilutions (data not shown).
We also determined the sensitivity of our cell assay by analyzing
the number of PrP
res-containing cells in the inoculated cultures. In
this assay, 50,000 cells from the same experiment shown in Fig. 1B
were filtered onto membranes of Elispot microtiter plates, the cells
were then lyzed, PK-digested and PrP
res was immunodetected
after guanidine hydrochloride (GdnHCl) denaturation. The re-
sulting spots, representing individual PrP
res-containing cells, are
depicted in Fig. 1C, (left) and were automatically counted with an
imaging equipment. Double-logarithmic plots of PG127 dilution
values versus detected spots are shown in Fig. 1C, (right). In our
conditions, the sensitivity of detection by Elispot was similar to that
by immunoblotting, i.e., positive transmission was observed for a
10
25 dilution of PG127 (42616 spots per 50,000 cells) and spot
number was linear between two logs of dilutions. Consistent with
immunoblot analysis (Fig. 1B), PrP
res from PG127 inoculum
diluted beyond 10
23 was not detected in inoculated, non
dox-treated cultures. Although Elispot and immunoblotting were
equally sensitive for detecting infected cultures in our experimental
conditions, these two techniques have distinct characteristics that
must be considered for their use in cell-based assays. The whole
Elispot procedure, including trypsinization, filtration, immunola-
belling of cells and counting is suitable to automatisation, which is
a major advantage for large scale titrations. Immunoblot detection
is less rapid and more labor intensive but does not rely on so-
phisticated equipments and allows analytical assessment of PrP
res.
In cultures infected with low doses of inoculum, a very small
number of cells has detectable PrP
res amounts (42 cells 616 cells
out of 50,000 cells for 10
25 dilution of PG127), suggesting that
infectivity is clustered in a very small number of highly infected
cells. We thought that physical disruption of these cells would
redistribute the prions, allowing infection of more cells during a
second round of cell-based assay. To test this possibility, duplicate
cultures of ovRK13 were inoculated, one series was lyzed one
month post-challenge while cells from each well from the 2
nd series
was homogenized and used to inoculate new ovRK13 cells for a
2
nd round of cell assay. PrP
res levels after one or two rounds were
analyzed by immunoblot. Typical results (Fig. 1D) revealed that
inoculated cultures that appear negative in the first round (10
26
and 10
27) contained infectivity that was detected upon a 2
nd round
of cell assay. Thus, performing two successive rounds dramatically
improved (by 100-fold) the cell assay sensitivity. Infectivity in 10
27
dilutions, not detected upon inoculation into tg338 mice, was
clearly evidenced through the ovRK13 cell assay.
MoRK13 cell assay of mouse RML prions
To determine the sensitivity of the RK13-based assay for prion
strains from other species, we chose RML, widely used in the
mouse scrapie model. Serial 10-fold dilutions of RML 10% brain
homogenate inoculated into tg20 mice showed that the last dilu-
tion inducing clinical disease in all mice (n=6) was 10
26 (the
incubation period was 108 days 66 days, mean 6 SD). Serial 10-
fold dilutions of this RML 10% brain homogenate (from 10
24 to
10
28) were inoculated to moRK13 cells. The cultures were
solubilized 4 weeks later, PK-digested and analyzed for the pre-
sence of PrP
res. Out of 8 independent experiments, all cultures
inoculated with 10
25 were PrP
res positive (a typical result is shown
in Fig. 2A). In two experiments, a PrP
res signal was also detected in
cells inoculated with the 10
26 dilution of RML. As observed with
ovine prions, a second round of cell assay increased the sensitivity
of RML detection by 100-fold (Fig. 2B), i.e., inoculated cultures
that appear negative in the first round (10
26 and 10
27) contained
infectivity that was detected upon a 2
nd round of cell assay. Thus,
10
27 dilutions that do not transmit disease to tg20 mice lead to a
detectable infection of moRK13 cultures.
Cell assay of prions bound to plastic surface
Prions strongly bind to stainless steel wires and the contam-
inated wires efficiently transmit disease to mice [38,39,40] and
infection to recipient cultured target cells [21]. Prion-coated wires,
as models of contaminated surgical metal devices, were used to
assess the effectiveness of decontamination procedures [38,39,41]
[21] [42] [43,44]. The propensity of prions for steel surface
binding led recently to a blood-based assay of vCJD [45]. There is
also suggestion that prions bound to tissue culture plastic may elicit
infection of seeded cultured cells [46]. To further examine this
possibility, the 10% PG127 homogenate was diluted in complete
culture medium and serial 10-fold dilutions were deposited for 2 h
in tissue culture plastic wells. Since it would be also useful to
detect prion infectivity in detergents buffers used in cell or tissue
fractionation [6,10] or in PMCA reactions [47,48], the 10%
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and deposited in plastic wells as well. The samples were then
removed, the wells thoroughly washed with PBS and air-dried for
2 h. OvRK13 cells were seeded into these wells and infection was
allowed to proceed for 4 weeks. We found (representative data
from 4 experiments are shown in Fig. 3) that infection of cultures
seeded in prion-coated wells was as efficient as that observed with
the standard procedure, i.e., cultures seeded in 10
25-coated wells
were PrP
res positive. Interestingly, coating and cell detection of
detergent-solubilized prions were also very effective. These findings
indicate that prions can be quantitatively detected by our cell assay
upon binding to plastic surfaces.
Discussion
The cell-based assay designed in this study allows a simple,
versatile, rapid, robust and sensitive detection of ovine-derived and
mouse RML prions. Since RK13 cells are permissive to several
Figure 1. Sensitivity of ovRK13 cell assay for the detection of PG127 ovine prion. A) Morphology of inoculated ovRK13 cultures kept in the
same wells during the whole cell assay procedure (d0 is the time of inoculation and d28 is 4 weeks later). B) Sensitivity of ovRK13 cell assay as
assessed by immunoblotting. Right panel: Serial 10-fold dilutions (from 10
24 to 10
26) of infectious PG127 10% brain homogenate were inoculated to
single wells of ovRK13 cells. Four weeks later, inoculated cultures were analyzed for PrP
res by immunoblotting. Positive transmission was detected for
dilutions up to 10
25. No PrP
res was observed when inoculated ovRK13 did not express the ovine PrP (dox-). Left panel: total PrP from infected cells was
analyzed before (2) or after (+) PK digestion to illustrate band shift upon PK proteolysis. M are standard molecular mass marker proteins (20, 30 and
40 kDa). C) Sensitivity of ovRK13 cell assay as assessed by Elispot. Replicate wells from the same experiment shown in Fig. 1B were analyzed. Left:
representative wells of an Elispot plate showing spots given by ovRK13 cells exposed to the indicated dilutions of PG127. Right: double-logarithmic
plot of spot number versus PG127 dilution shown for inoculations in the presence (triangle) or in the absence (square) of dox. For each dilution, the
mean value 6 SD of 8 measurements is shown. Background values for ovRK13 cells inoculated in the absence of dox are less than 4 spots per 50,000
cells. D) Sensitivity is strongly improved by 2 successive rounds of cell assay. Serial 10-fold dilutions (from 10
25 to 10
27) of infectious PG127 10% brain
homogenate were inoculated to duplicate wells of ovRK13 cells. Four weeks later, PrP
res in a 1
st set of inoculated cultures was isolated (1
st round)
while cultures of the 2
nd set were homogenized to inoculate new ovRK13 cells. Four weeks later, PrP
res was isolated (2
nd round) and all the samples
were analyzed by immunoblotting. M are standard molecular mass marker proteins (20, 30 and 40 kDa).
doi:10.1371/journal.pone.0020563.g001
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1, RML and MU-02 strains of mouse prions [27,28,29], to a strain
of bank vole prions [27], the procedure described here should be
useful for an easy and sensitive detection of a wide range of prions.
Notably, it should improve and/or facilitate the recently reported
RK13-based titration of Chronic Wasting Disease agent [32].Per-
forming two successive rounds of infection increased the sensitivity
of the ovRK13 and moRK13 cell-based assays by a 100-fold,
allowing detection of infectivity in 10
27 dilutions of 10% PG127
and RML homogenates, albeit at the cost of prolonging the assay
time. In that case, sensitivity of the RK13 cell assay appears similar
to that of the mouse bioassay. The amount of 10% PG127 or
RML brain homogenates to infect ovRK13 or moRK13 cells,
respectively, was 3 10
24 ml (3,000 ml 610
27). This is very similar
to the lower amount of 10% PG127 or RML that transmits disease
to 100% of tg338 or tg20 mice, i.e., 21 0
24 ml (20 ml 610
25).
Considering that 3,000 ml of PG127 at a 10
25 dilution resulted in
42 spots (cell units), there are about 1.3 10
6 cell units/ml of 10%
PG127. Since a second round increases the sensitivity by about
100-fold, we estimate that 10% PG127 contains about 1.3 10
8 cell
units/ml, a value closed to the titer obtained by tg338 bioassay
(10
7.7 LD50/ml). The accurate comparison of moRK13 sensitivity
to that of other cell lines widely used for mouse prion titration (e.g.,
PK1, CAD5, LD9) would require the use of the same RML
preparations. However, these cell lines led to a detectable infection
for RML dilutions up to 10
25–10
26 (10
26–10
27 in the designa-
tion’s authors as their 10% RML brain homogenate was set as the
10
21 dilution) [18,49]. This suggests that moRK13 cells have a
sensitivity roughly similar to these lines.
In sharp contrast to the other cell lines previously used to
titrate mouse [18] and sheep prions [50], no subcultivation of
inoculated RK13 epithelial cultures is required before analysis.
This unique feature is a crucial operational advantage as serial
passaging of inoculated cultures is very time-consuming and
costly, especially when assaying large numbers of samples. For
example, inoculated MovS cultures [51] have to be passaged 8
times for optimal PG127 detection [50]. In addition, the slow
down of cell division may participate in high sensitivity of the
assay as cell division was reported to decrease steady state levels
of PrP
res [52]. In contrast with N2a and other sublines whose
susceptibility is not preserved during prolonged subcultivation
[18], we did not observe any decline in sensitivity when ovRK13
and moRK13 cells were serially passaged for six months (i.e.,
24 serial 1:4 splits, longer periods of subcultivation were
not systematically explored). Such stability contributes to the
ease-of-use of the RK13 cell assay.
The binding of prions onto a plastic surface is a further example
of prion avidity for various surfaces including steel [38,40] and soil
particles [53]. This amazing propensity of prions to bind solid
surfaces and/or particles is an efficient and inexpensive mean to
concentrate prions as illustrated by the detection of steel-bound
vCJD blood prions [45]. How prions adsorb to these surfaces is
unknown but there is compelling evidence that bound prions
remain infectious [20,21,38,54]. Further studies are underway to
establish whether small amounts of prions in biological fluids can be
concentrated onto plastic surface and be detected by our cell assay.
Over the recent past years, cell-based assays have proven to be
valuable tools for prion detection and titration. We believe that
our easy to handle and labor non intensive RK13-based assay will
further contribute to routine detection of prions and may help to
substitute cultured cells for animal bioassay in various aspects of
prion research. In addition, the remarkable binding property of
prions to tissue culture plastic should allow routine detection of
prion infectivity in samples that are toxic for cells, including those
from PMCA reactions.
Materials And Methods
Ethics statement
All animal experiments were performed in compliance with our
institutional and national guidelines, in accordance with the Euro-
pean Community Council Directive 86/609/EEC. The experi-
mental protocols were approved by the INRA Toulouse/ENVT
ethics committees, and were performed in the approved animal
facilities (C 31 555 27) of author’s institution by an agreed ex-
perimentator (311055503).
Cells
OvRK13 cells expressing the ovine PrP protein (the Rov9 clone)
have been previously described [31]. We generated moRK13 cells
Figure 2. Sensitivity of moRK13 cell assay for the detection of
RML mouse prions. Serial 10-fold dilutions (from 10
24 to 10
28)o f
RML 10% brain homogenate were inoculated in duplicate to moRK13
cells and the inoculated cultures were proceeded as in figure 1D. PrP
res
was analyzed by western blot after one (A) or two rounds (B) of cell
assay. M are standard molecular mass marker proteins in kDa.
doi:10.1371/journal.pone.0020563.g002
Figure 3. Cell assay detection of plastic-bound prions. Infectivity
from 10% PG127 brain homogenate was diluted either in culture
medium (prion in culture medium) or in Triton-DOC lysis buffer (prion in
detergents) and incubated for 2 h into plastic wells. Samples were
removed, wells were thoroughly rinsed and air-dried. OvRK13 cells were
then seeded in the presence (+) or in the absence (2) of dox. PrP
res in
the cultures was analyzed 4 weeks later by immunoblotting and
compared to PrP
res levels in ovRK13 cultures subjected to the standard
cell assay (no coating). M are standard molecular mass marker proteins
(20, 30 and 40 kDa).
doi:10.1371/journal.pone.0020563.g003
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and the cell clone used in this study was mo1. The cells were
maintained at 37uC in 5% CO2 in Opti-MEM medium (In-
vitrogen) supplemented with 10% fetal bovine serum, 100 U/ml
penicillin, and 10 mg/ml streptomycin. To induce the expres-
sion of ovine or mouse PrP, 1 mg/ml doxycycline (Sigma-Aldrich)
was added to the culture medium.
Prion agents
The sheep isolate (PG127)[33], propagated once in sheep, was
amplified in tg338 mice [34] and prepared as described previously
[6]. The mouse RML strain was propagated in C57BL/6 mice. At
the terminal stage, brains were homogenized at 10% (wt/vol) in
5% sterile glucose using a high-speed homogenizer (TeSeE Precess
48 system).
Cell-based assay procedure
OvRK13 or moRK13 cells were seeded in six-well plates (TPP)
with or without doxycycline treatment. When confluent, the
cultures were exposed to 3 ml of culture medium containing serial
10-fold dilutions of the PG127 or RML 10% infectious brain
homogenates. One week later, the media were renewed. Infection
was allowed to proceed for 3 more weeks with one medium change
per week. At the end, the cells were either solubilized for im-
munoblot analysis of PrP
res or processed for Elispot detection of
PrP
res-containing cells. Alternatively, the cells were trypsinized, the
cell pellets from each well were resuspended in 500 ml of 5% sterile
glucose and were homogenized with the high-speed homogenizer.
Half of the resulting cell extracts was used to inoculate ovRK13 or
moRK13 cells for a second round of cell assay.
Coating of prions to plastic
Threeml of 10% PG127 brain homogenate (this corresponds to
the amount of PG127 in 3 ml of a 10
23 dilution) were diluted into
250 ml of culture medium and then serially diluted 10-fold into
250 ml of culture medium. Alternatively, the same amount of
PG127 was diluted into 250 ml of normal sheep brain proteins
(1 mg/ml) solubilized in Triton-DOC lysis buffer and further
diluted 10-fold into the same buffer. All the samples (250 ml) were
incubated into pre-wet polystyrene wells of six-well plates (TPP) at
room temperature with occasional agitation. Two hours later, the
samples were removed, the wells were washed twice with 3 ml of
PBS and air dried for 2 h. OvRK13 cells (300,000 cells in 3 ml of
culture medium with or without dox, as indicated) were seeded
into the wells and the cultures were kept for 4 weeks with one
medium change every week.
Immunoblotting detection of PrP
res in inoculated cultures
Cell cultures were rinsed with cold PBS and solubilized for 10 min
at 4uC in Triton-DOC lysis buffer (50 mM Tris/HCl (pH 7.4), 0.5%
Triton-X100, 0.5% sodium deoxycholate). The lysates were clarified
by low speed centrifugation (425 X g, 1 min) and cellular proteins in
the post-nuclear supernatants were quantified by bicinchoninic acid
(BCA, Pierce). Digestion of 750 mg – 1,000 mg of proteins with PK
(recombinant grade, Roche) was performed for 2 h at 37uCw i t ha
mass ratio of 4 mg of PK per mg of cellular proteins and the reaction
was stopped by addition of Pefabloc (Sigma-Aldrich) to 4 mM. PK-
digested samples were centrifuged for 30 min at 20,000 X gand pellets
were analyzed by western blot. Samples separated by 12% SDS-
PAGE electrophoresis were transferred to PVDF membranes (Bio-
Rad). The western blots were stained for PrP with Sha31 mAb [55].
Filters were developed using an ECL+ reagent kit (Amersham-GE
Healthcare) and visualized with a Bio-Rad VersaDoc imaging system.
Elispot detection of infected cells
The procedure has been described in detail [56]. Trypsinized
cells were resuspended in PBS and 50,000 cells were aspirated into
each well of a Multiscreen 96-well filter plate (Millipore). The plate
was incubated at 50uC for 1 h. Dried wells were incubated for
30 min at 37uC with 20 mg/ml of PK in Triton-DOC lysis buffer
and digestion was stopped with 4 mM Pefabloc. Proteins were
denatured with GdnHCl 8 M in PBS for 10 min. Filters were
saturated for 1 h with 0.5% BSA in tris-buffered saline with
tween20 (TBST), incubated with Sha31 mAb and then with
peroxidase-coupled secondary antibody. Bound antibodies were
visualized with TMB stabilized substrate for horseradish peroxi-
dase (Promega) and spots were detected and enumerated with an
Elispot reader system (AID GmbH).
Mice bioassays
10% PG127 or 10% RML brain homogenates were serially 10-
fold diluted into Opti-MEM medium supplemented with 10%
fetal bovine serum, 100 U/ml penicillin, and 10 mg/ml strepto-
mycin, and 20 ml were inoculated intracerebrally into tg338 [34] or
tg20 [57] mice, respectively. Mice were then clinically monitored
until the occurrence of scrapie clinical signs, at which time they
were euthanized.
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